Managing potential laboratory exposure to Ebola virus by using a patient biocontainment care unit

Mark G Kortepeter, James W. Martin, Janice M. Rusnak, Theodore J Cieslak, Kelly L. Warfield, Edwin L. Anderson, Manmohan V. Ranadive

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

In 2004, a scientist from the US Army Medical Research Institute of Infectious Diseases (USAMRIID) was potentially exposed to a mouse-adapted variant of the Zaire species of Ebola virus. The circumstances surrounding the case are presented, in addition to an update on historical admissions to the medical containment suite at USAMRIID. Research facilities contemplating work with pathogens requiring Biosafety Level 4 laboratory precautions should be mindful of the occupational health issues highlighted in this article.

Original languageEnglish (US)
Pages (from-to)881-887
Number of pages7
JournalEmerging infectious diseases
Volume14
Issue number6
DOIs
StatePublished - Jan 1 2008

Fingerprint

Ebolavirus
Communicable Diseases
Biomedical Research
Patient Care
Occupational Health
Research

ASJC Scopus subject areas

  • Epidemiology
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Managing potential laboratory exposure to Ebola virus by using a patient biocontainment care unit. / Kortepeter, Mark G; Martin, James W.; Rusnak, Janice M.; Cieslak, Theodore J; Warfield, Kelly L.; Anderson, Edwin L.; Ranadive, Manmohan V.

In: Emerging infectious diseases, Vol. 14, No. 6, 01.01.2008, p. 881-887.

Research output: Contribution to journalArticle

Kortepeter, Mark G ; Martin, James W. ; Rusnak, Janice M. ; Cieslak, Theodore J ; Warfield, Kelly L. ; Anderson, Edwin L. ; Ranadive, Manmohan V. / Managing potential laboratory exposure to Ebola virus by using a patient biocontainment care unit. In: Emerging infectious diseases. 2008 ; Vol. 14, No. 6. pp. 881-887.
@article{248d38223d6842d9a5304c86402a59f5,
title = "Managing potential laboratory exposure to Ebola virus by using a patient biocontainment care unit",
abstract = "In 2004, a scientist from the US Army Medical Research Institute of Infectious Diseases (USAMRIID) was potentially exposed to a mouse-adapted variant of the Zaire species of Ebola virus. The circumstances surrounding the case are presented, in addition to an update on historical admissions to the medical containment suite at USAMRIID. Research facilities contemplating work with pathogens requiring Biosafety Level 4 laboratory precautions should be mindful of the occupational health issues highlighted in this article.",
author = "Kortepeter, {Mark G} and Martin, {James W.} and Rusnak, {Janice M.} and Cieslak, {Theodore J} and Warfield, {Kelly L.} and Anderson, {Edwin L.} and Ranadive, {Manmohan V.}",
year = "2008",
month = "1",
day = "1",
doi = "10.3201/eid1406.071489",
language = "English (US)",
volume = "14",
pages = "881--887",
journal = "Emerging Infectious Diseases",
issn = "1080-6040",
publisher = "Centers for Disease Control and Prevention (CDC)",
number = "6",

}

TY - JOUR

T1 - Managing potential laboratory exposure to Ebola virus by using a patient biocontainment care unit

AU - Kortepeter, Mark G

AU - Martin, James W.

AU - Rusnak, Janice M.

AU - Cieslak, Theodore J

AU - Warfield, Kelly L.

AU - Anderson, Edwin L.

AU - Ranadive, Manmohan V.

PY - 2008/1/1

Y1 - 2008/1/1

N2 - In 2004, a scientist from the US Army Medical Research Institute of Infectious Diseases (USAMRIID) was potentially exposed to a mouse-adapted variant of the Zaire species of Ebola virus. The circumstances surrounding the case are presented, in addition to an update on historical admissions to the medical containment suite at USAMRIID. Research facilities contemplating work with pathogens requiring Biosafety Level 4 laboratory precautions should be mindful of the occupational health issues highlighted in this article.

AB - In 2004, a scientist from the US Army Medical Research Institute of Infectious Diseases (USAMRIID) was potentially exposed to a mouse-adapted variant of the Zaire species of Ebola virus. The circumstances surrounding the case are presented, in addition to an update on historical admissions to the medical containment suite at USAMRIID. Research facilities contemplating work with pathogens requiring Biosafety Level 4 laboratory precautions should be mindful of the occupational health issues highlighted in this article.

UR - http://www.scopus.com/inward/record.url?scp=45249089922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45249089922&partnerID=8YFLogxK

U2 - 10.3201/eid1406.071489

DO - 10.3201/eid1406.071489

M3 - Article

VL - 14

SP - 881

EP - 887

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

SN - 1080-6040

IS - 6

ER -